Journal of thrombosis and thrombolysis
-
J. Thromb. Thrombolysis · Aug 2004
Tenecteplase for the treatment of massive and submassive pulmonary embolism.
Data on thrombolytic therapy disclose benefits from thrombolytic therapy in patients with massive and submassive pulmonary embolism (PE). Previously published case reports have described the successful use of tenecteplase under these conditions. ⋯ These data support the use of this new thrombolytic agent in patients with massive and submassive PE; however, sufficiently powered, randomized trials have not yet taken place for these indications.